JPH0542413B2 - - Google Patents

Info

Publication number
JPH0542413B2
JPH0542413B2 JP58225079A JP22507983A JPH0542413B2 JP H0542413 B2 JPH0542413 B2 JP H0542413B2 JP 58225079 A JP58225079 A JP 58225079A JP 22507983 A JP22507983 A JP 22507983A JP H0542413 B2 JPH0542413 B2 JP H0542413B2
Authority
JP
Japan
Prior art keywords
human
protein
cells
dna
vol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP58225079A
Other languages
English (en)
Japanese (ja)
Other versions
JPS60115528A (ja
Inventor
Koichi Kato
Takahisa Yamada
Haruo Onda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=16823684&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPH0542413(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Priority to JP58225079A priority Critical patent/JPS60115528A/ja
Priority to IL73530A priority patent/IL73530A0/xx
Priority to AU35756/84A priority patent/AU592527C/en
Priority to SG1996004789A priority patent/SG46452A1/en
Priority to EP96201538A priority patent/EP0751220A1/en
Priority to EP19910105904 priority patent/EP0442538A1/en
Priority to EP84308153A priority patent/EP0145390A3/en
Priority to ZA849221A priority patent/ZA849221B/xx
Priority to GR81040A priority patent/GR81040B/el
Priority to NZ210352A priority patent/NZ210352A/xx
Priority to HU844383A priority patent/HU200793B/hu
Priority to ES537994A priority patent/ES8606489A1/es
Priority to KR1019840007430A priority patent/KR920006879B1/ko
Priority to DK560784A priority patent/DK164174C/da
Priority to NO844710A priority patent/NO169021C/no
Priority to PT79555A priority patent/PT79555B/pt
Priority to FI844678A priority patent/FI81118C/fi
Priority to CN 85101341 priority patent/CN1007906B/zh
Publication of JPS60115528A publication Critical patent/JPS60115528A/ja
Priority to MYPI87002002A priority patent/MY103892A/en
Priority to US07/942,358 priority patent/US5464939A/en
Publication of JPH0542413B2 publication Critical patent/JPH0542413B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP58225079A 1983-11-28 1983-11-28 ヒトインタ―ロイキン―２蛋白質を含有する抗腫瘍用または免疫機能低下疾患治療用組成物 Granted JPS60115528A (ja)

Priority Applications (20)

Application Number Priority Date Filing Date Title
JP58225079A JPS60115528A (ja) 1983-11-28 1983-11-28 ヒトインタ―ロイキン―２蛋白質を含有する抗腫瘍用または免疫機能低下疾患治療用組成物
IL73530A IL73530A0 (en) 1983-11-28 1984-11-16 Highly purified protein,production and use thereof
AU35756/84A AU592527C (en) 1983-11-28 1984-11-21 Non-glycosylated human interleukin-2 recombinant production
SG1996004789A SG46452A1 (en) 1983-11-28 1984-11-23 High purified protein production and use therof
EP96201538A EP0751220A1 (en) 1983-11-28 1984-11-23 Highly purified protein, production and use thereof
EP19910105904 EP0442538A1 (en) 1983-11-28 1984-11-23 High purified protein, production and use thereof
EP84308153A EP0145390A3 (en) 1983-11-28 1984-11-23 A method for producing non-glycosylated human interleukin-2 protein
ZA849221A ZA849221B (en) 1983-11-28 1984-11-26 Highyl purified protein,production and use thereof
GR81040A GR81040B (en) 1983-11-28 1984-11-26 Highly purified protein, production and use thereof
HU844383A HU200793B (en) 1983-11-28 1984-11-27 Genetic engineering technique for producing new, human interleukin-2 protein
PT79555A PT79555B (en) 1983-11-28 1984-11-27 Highly purified protein production and use thereof
NZ210352A NZ210352A (en) 1983-11-28 1984-11-27 Interleukin-2- highly purified
ES537994A ES8606489A1 (es) 1983-11-28 1984-11-27 Un metodo de producir una proteina de interleuquina-2-humana no glicosilada sustancialmente pura
KR1019840007430A KR920006879B1 (ko) 1983-11-28 1984-11-27 고정제 단백질의 제조방법
DK560784A DK164174C (da) 1983-11-28 1984-11-27 Et i det vaesentlige rent, ikke-glykolyseret humant interleukin-2-protein, fremgangsmaade til fremstilling af dette protein og farmaceutisk produkt indeholdende dette protein
NO844710A NO169021C (no) 1983-11-28 1984-11-27 Fremgangsmaate for fremstilling av vesentlig rent uglykosylert humant interleukin-2-protein
FI844678A FI81118C (fi) 1983-11-28 1984-11-28 Foerfarande foer framstaellning av vaesentligen rent interleukin-2 protein.
CN 85101341 CN1007906B (zh) 1983-11-28 1985-04-01 高纯度蛋白质的制备及其应用
MYPI87002002A MY103892A (en) 1983-11-28 1987-09-28 Interleukin-2 of high purity production and use
US07/942,358 US5464939A (en) 1983-11-28 1992-09-09 Highly purified protein, production and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58225079A JPS60115528A (ja) 1983-11-28 1983-11-28 ヒトインタ―ロイキン―２蛋白質を含有する抗腫瘍用または免疫機能低下疾患治療用組成物

Publications (2)

Publication Number Publication Date
JPS60115528A JPS60115528A (ja) 1985-06-22
JPH0542413B2 true JPH0542413B2 (enExample) 1993-06-28

Family

ID=16823684

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58225079A Granted JPS60115528A (ja) 1983-11-28 1983-11-28 ヒトインタ―ロイキン―２蛋白質を含有する抗腫瘍用または免疫機能低下疾患治療用組成物

Country Status (16)

Country Link
US (1) US5464939A (enExample)
EP (3) EP0442538A1 (enExample)
JP (1) JPS60115528A (enExample)
KR (1) KR920006879B1 (enExample)
DK (1) DK164174C (enExample)
ES (1) ES8606489A1 (enExample)
FI (1) FI81118C (enExample)
GR (1) GR81040B (enExample)
HU (1) HU200793B (enExample)
IL (1) IL73530A0 (enExample)
MY (1) MY103892A (enExample)
NO (1) NO169021C (enExample)
NZ (1) NZ210352A (enExample)
PT (1) PT79555B (enExample)
SG (1) SG46452A1 (enExample)
ZA (1) ZA849221B (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925919A (en) * 1984-04-25 1990-05-15 Roland Mertelsmann Purified interleukin 2
US4992271A (en) * 1982-09-23 1991-02-12 Cetus Corporation Formulation for lipophilic IL-2 proteins
US4853332A (en) * 1982-10-19 1989-08-01 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of biologically active proteins
DK174501B1 (da) * 1983-12-23 2003-04-28 Hoffmann La Roche Fremgangsmåde til fremstilling af interleukin-2
US4569790A (en) * 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
JPS60243021A (ja) * 1984-03-28 1985-12-03 シタス　コ−ポレイシヨン システイン含有蛋白質の制御された酸化方法
EP0158487B1 (en) * 1984-04-09 1991-08-28 Takeda Chemical Industries, Ltd. Stable composition of interleukin-2
US4908434A (en) * 1984-04-25 1990-03-13 Sloan-Kettering Institute For Cancer Research Process for preparing purified interleukin-2
US4908433A (en) * 1984-04-25 1990-03-13 Sloan-Kettering Institute For Cancer Research Uses of interleukin-2
WO1986002068A1 (fr) * 1984-09-26 1986-04-10 Takeda Chemical Industries, Ltd. Separation mutuelle de proteines
IL76360A0 (en) 1984-09-26 1986-01-31 Takeda Chemical Industries Ltd Mutual separation of proteins
JPH0646957B2 (ja) * 1985-03-11 1994-06-22 武田薬品工業株式会社 インタ−ロイキン−２の製造方法
EP0226639B1 (en) * 1985-05-29 1990-11-14 The Green Cross Corporation Process for preparing heterogenic protein
US4748234A (en) * 1985-06-26 1988-05-31 Cetus Corporation Process for recovering refractile bodies containing heterologous proteins from microbial hosts
WO1987000553A1 (fr) * 1985-07-16 1987-01-29 The Green Cross Corporation Procede de preparation d'hetero-proteine
DE3526096A1 (de) * 1985-07-22 1987-01-22 Basf Ag Verfahren zur reinigung von htnf
CN86104525A (zh) * 1985-07-31 1987-02-25 武田药品工业株式会社 人类白细胞介素-2的分析方法和试剂
DK585886A (da) * 1985-12-24 1987-06-25 Takeda Chemical Industries Ltd Immunstimulerende middel og anvendelse deraf
US4933433A (en) * 1986-01-31 1990-06-12 E. I. Du Pont De Nemours And Company Recombinant interleukin-2 composition and process for making it
JPH0655153B2 (ja) * 1986-02-26 1994-07-27 武田薬品工業株式会社 ヒトインターロイキン―２結晶の製造法
US4929700A (en) * 1987-04-16 1990-05-29 Cetus Corporation Production of purified, biologically active, bacterially produced recombinant human CSF-1
CA1339757C (en) 1987-04-16 1998-03-17 Robert F. Halenbeck Production of purified biologically active, bacterially produced recombinant human csf-1
US4961969A (en) * 1987-05-11 1990-10-09 Cetus Corporation Process for recovering microbially produced interferon-β
US4931543A (en) * 1987-05-11 1990-06-05 Cetus Corporation Process for recovering microbially produced interleukin-2
US5149788A (en) * 1987-05-19 1992-09-22 Hoffmann-La Roche, Inc. Purification of chimeric proteins containing an IL-2 moiety by receptor-affinity chromatography
US5162503A (en) * 1987-05-19 1992-11-10 Hoffmann-La Roche, Inc. Purification of interleukin-2 by receptor-affinity chromatography
FR2635527B1 (fr) * 1988-07-28 1992-06-12 Roussel Uclaf Il2 humaine recombinante non glycosylee sous forme reduite, son procede d'obtention et son application comme medicament
US5250296A (en) * 1990-11-29 1993-10-05 Takeda Chemical Industries, Ltd. Immunostimulant agent containing interleukin-2 and 5'-deoxy-5-fluorouridine
US5416071A (en) * 1991-03-12 1995-05-16 Takeda Chemical Industries, Ltd. Water-soluble composition for sustained-release containing epo and hyaluronic acid
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
EP1278767A4 (en) 2000-04-12 2003-11-12 Principia Pharmaceutical Corp ALBUMIN FUSED PROTEINS
EP2277889B1 (en) 2001-12-21 2014-07-09 Human Genome Sciences, Inc. Fusion proteins of albumin and interferon beta
CA2513213C (en) 2003-01-22 2013-07-30 Human Genome Sciences, Inc. Albumin fusion proteins
GB201000693D0 (en) 2010-01-15 2010-03-03 Isis Innovation A solar cell
JP2014506116A (ja) * 2010-11-12 2014-03-13 ウェルズ ファーゴ バンク ナショナル アソシエイション Ｉｌ−２部分とポリマーとのコンジュゲート
CA2963602A1 (en) 2014-10-09 2016-04-14 Dana-Farber Cancer Institute, Inc. Multiple-variable il-2 dose regimen for treating immune disorders

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58116498A (ja) * 1981-12-28 1983-07-11 Takeda Chem Ind Ltd Ｉｌ‐２をコードする新規伝令ｒｎａの製造法
JPH0751511B2 (ja) * 1982-03-15 1995-06-05 味の素株式会社 インターロイキン２を含有してなる癌治療剤
CA1210714A (en) * 1982-03-23 1986-09-02 Alan Sloma .alpha.-INTERFERON GX-1
DE3377363D1 (en) * 1982-03-31 1988-08-18 Ajinomoto Kk Gene coding for interleukin-2 polypeptide, recombinant dna carrying said gene, cell lines possessing the recombinant dna,and method for producing interleukin-2 using said cells
JPS58201979A (ja) * 1982-05-18 1983-11-25 Japan Found Cancer ヒトインタ−ロイキン２遺伝子が組込まれているエシエリヒア・コリおよびその育種方法
CA1341562C (en) * 1982-03-31 2007-11-27 Tadatsugu Taniguchi Gene coded for interleukin-2 polypeptide, recombinant dna carrying the said gene, a living cell line possessing the recombinant dna, and method for producing interleukin-2 using the said cell
JPS58168492A (ja) * 1982-03-31 1983-10-04 Nippon Kokan Kk <Nkk> パイプ切断機
EP0092163B1 (en) * 1982-04-20 1988-09-28 Sloan-Kettering Institute For Cancer Research Purification of interleukin 2
JPS58198293A (ja) * 1982-05-12 1983-11-18 Shionogi & Co Ltd インタ−ロイキン等免疫調節因子の製造方法
NL8203321A (nl) * 1982-08-25 1984-03-16 Philips Nv Kleurenbeeldbuis.
US4490289A (en) * 1982-09-16 1984-12-25 Hoffmann-La Roche Inc. Homogeneous human interleukin 2
AU579089B2 (en) * 1983-02-08 1988-11-17 Biogen, Inc. Human interleukin-2-like polypeptides
ZA842025B (en) * 1983-03-21 1984-11-28 Hoffmann La Roche Interleuken-2
US4518584A (en) * 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
EP0162898A4 (en) * 1983-11-14 1987-07-23 Chiron Corp INTERLEUKIN-2 GENERATION USING CLONED GENES FOR INTERLEUKIN-2 AND YEAR ALPHA FACTOR.
DK174501B1 (da) * 1983-12-23 2003-04-28 Hoffmann La Roche Fremgangsmåde til fremstilling af interleukin-2
US4569790A (en) * 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
US4530787A (en) * 1984-03-28 1985-07-23 Cetus Corporation Controlled oxidation of microbially produced cysteine-containing proteins
JP2608730B2 (ja) * 1987-08-10 1997-05-14 株式会社リコー 感熱記録材料

Also Published As

Publication number Publication date
SG46452A1 (en) 1998-02-20
EP0751220A1 (en) 1997-01-02
FI81118B (fi) 1990-05-31
US5464939A (en) 1995-11-07
PT79555B (en) 1986-12-15
AU3575684A (en) 1985-06-06
FI844678A0 (fi) 1984-11-28
PT79555A (en) 1984-12-01
KR920006879B1 (ko) 1992-08-21
NO169021B (no) 1992-01-20
KR850003734A (ko) 1985-06-26
ZA849221B (en) 1986-07-30
HUT36186A (en) 1985-08-28
GR81040B (en) 1985-03-27
EP0145390A2 (en) 1985-06-19
ES537994A0 (es) 1986-04-01
DK164174B (da) 1992-05-18
EP0145390A3 (en) 1987-01-21
IL73530A0 (en) 1985-02-28
FI844678L (fi) 1985-05-29
EP0442538A1 (en) 1991-08-21
AU592527B2 (en) 1990-01-18
DK560784A (da) 1985-05-29
NZ210352A (en) 1988-11-29
JPS60115528A (ja) 1985-06-22
ES8606489A1 (es) 1986-04-01
MY103892A (en) 1993-10-30
DK560784D0 (da) 1984-11-27
HU200793B (en) 1990-08-28
FI81118C (fi) 1990-09-10
DK164174C (da) 1992-10-05
NO844710L (no) 1985-05-29
NO169021C (no) 1992-04-29

Similar Documents

Publication Publication Date Title
JPH0542413B2 (enExample)
KR100230156B1 (ko) 종양괴사인자 억제제 및 그 제조방법
JP2515308B2 (ja) ヒト免疫インタ−フエロン
JP2865300B2 (ja) ヒトｂ細胞刺激因子２レセプター蛋白質
KR0148009B1 (ko) 인터루킨-1 억제제
KR100439290B1 (ko) 인터로이칸-18을인식하는신규의폴리펩티드
JP2541761B2 (ja) ミュレル管抑制物質様ポリペプチドおよびその製造方法
EP0319012A2 (en) Immobilized interleukin 2 and interleukin 2 containing a carboxyl-terminal extension
JP2011102302A (ja) ヒトインターロイキン４のアンタゴニストもしくは部分的アゴニストとして使用されるｈＩＬ−４突然変異蛋白質
KR970002917B1 (ko) 인터루킨-i 억제제
JPH0536414B2 (enExample)
CN107022032A (zh) 用于调节铁稳态的组合物及其使用方法
JPH03500415A (ja) インターロイキン２類似体
JPH06220099A (ja) 可溶性ｌｄｌリセプター
JP2633295B2 (ja) ヒトａｄｆをコードする遺伝子
KR100382628B1 (ko) 인터페론α/β결합단백질과이의제조및용도
WO2023217288A1 (zh) 新融合蛋白及其用途
JPH02273193A (ja) 組換えインターロイキン―２融合蛋白質類
US6465616B1 (en) Interleukin-5 antagonist
JP2555816B2 (ja) ヒトインターロイキン−２蛋白質の製造法
JP2601199B2 (ja) ヒトインターロイキン−２蛋白質
CA2256368A1 (en) An interleukin-5 antagonist
JP2890326B2 (ja) 遺伝子及びその製造法
KR960016305B1 (ko) 온코스타틴 m 및 항신생물 활성을 갖는 신규 조성물
AU723413B2 (en) An interleukin-5 antagonist